rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2010-4-14
|
pubmed:abstractText |
Despite the observed association between diabetes mellitus and hepatocellular carcinoma (HCC), little is known about the effect of diabetes duration before HCC diagnosis and whether some diabetes medications reduced the risk of HCC development. This objective of the current study was to determine the association between HCC risk and diabetes duration and type of diabetes treatment.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0008-543X
|
pubmed:author |
pubmed-author:AbbruzzeseJames LJL,
pubmed-author:AbdallaEddie KEK,
pubmed-author:CurleySteven ASA,
pubmed-author:DavilaMartaM,
pubmed-author:HassanManal MMM,
pubmed-author:JavleMilindM,
pubmed-author:KasebAhmedA,
pubmed-author:LiDonghuiD,
pubmed-author:LozanoRichard DRD,
pubmed-author:MoghazyDalia MDM,
pubmed-author:VautheyJean-NicolasJN
|
pubmed:copyrightInfo |
(c) 2010 American Cancer Society.
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
116
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1938-46
|
pubmed:meshHeading |
pubmed-meshheading:20166205-Adult,
pubmed-meshheading:20166205-Aged,
pubmed-meshheading:20166205-Carcinoma, Hepatocellular,
pubmed-meshheading:20166205-Case-Control Studies,
pubmed-meshheading:20166205-Diabetes Complications,
pubmed-meshheading:20166205-Diabetes Mellitus,
pubmed-meshheading:20166205-Female,
pubmed-meshheading:20166205-Humans,
pubmed-meshheading:20166205-Liver Neoplasms,
pubmed-meshheading:20166205-Male,
pubmed-meshheading:20166205-Metformin,
pubmed-meshheading:20166205-Middle Aged,
pubmed-meshheading:20166205-Risk Factors,
pubmed-meshheading:20166205-Sulfonylurea Compounds
|
pubmed:year |
2010
|
pubmed:articleTitle |
Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma.
|
pubmed:affiliation |
Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. mhassan@mdanderson.org
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|